Readystate Asset Management »

Mersana Therapeutics shares owned by Readystate Asset Management

Quarter-by-quarter ownership of Mersana Therapeutics (MRSN) shares owned by Readystate Asset Management from 13F filings

Historical chart of Readystate Asset Management investment in Mersana Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mersana Therapeutics held by Readystate Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mersana Therapeutics by Readystate Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $685k 295k 2.32
2023-06-30 $1.9M 567k 3.29

More positions owned by Readystate Asset Management

Ishares Tr Russell 2000 Etf Call Option (IWM)
Pfizer Call Option (PFE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Alnylam Pharmaceuticals Note 1.000% 9/1 (Principal)
Apple Call Option (AAPL)
Microsoft Corporation Call Option (MSFT)
Wolfspeed Note 1.875%12/0 (Principal)
Select Sector Spdr Tr Financial (XLF)
Lantheus Hldgs Note 2.625%12/1 (Principal)
Sarepta Therapeutics Note 1.250% 9/1 (Principal)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Alphatec Hldgs Note 0.750% 8/0 (Principal)
Veradigm Note 0.875% 1/0 (Principal)
Builders FirstSource Put Option (BLDR)
Peabody Energy Corp Note 3.250% 3/0 (Principal)

View all positions for Readystate Asset Management

Top funds holding Mersana Therapeutics

EcoR1 Capital
VR Adviser
Balyasny Asset Management
Vanguard Group
Nextech Invest
Millennium Management
Citadel Advisors
5AM Venture Management
Schonfeld Strategic Advisors
Deutsche Bank Aktiengesellschaft
Baker Bros. Advisors
Jacobs Levy Equity Management
D. E. Shaw & Co
Bank of New York Mellon
Jane Street

View all funds holding Mersana Therapeutics